InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (39 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
39
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Boulding Mark Elliott, Vice-Président Exécutif et Directeur Juridique. Director active across 1 company, notably PTC Therapeutics, INC.. In total, 70 disclosures have been logged. Breakdown: 0 buy · 39 sells. Total volume traded: €2.7m. History available since 8 July 2021. The latest transaction was filed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Boulding Mark Elliott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations70 total
2,813 shares@ US$25.69Common StockSEC:0001578852-26-000022:0
1,844 shares@ US$72.39Common StockSEC:0001578852-26-000022:1
969 shares@ US$72.90Common StockSEC:0001578852-26-000022:2
601 shares@ US$86.380.0007% mcap0.8% of flowCommon StockSEC:0001578852-26-000020:4
2,266 shares@ US$39.420.0012% mcap1.4% of flowCommon StockSEC:0001578852-26-000020:0
313 shares@ US$83.100.0004% mcap0.4% of flowCommon StockSEC:0001578852-26-000020:1
833 shares@ US$84.410.0009% mcap1.1% of flowCommon StockSEC:0001578852-26-000020:2
519 shares@ US$85.840.0006% mcap0.7% of flowCommon StockSEC:0001578852-26-000020:3
2,813 shares@ US$46.540.0018% mcap2.0% of flowCommon StockSEC:0001578852-26-000020:5
387 shares@ US$83.100.0004% mcap0.5% of flowCommon StockSEC:0001578852-26-000020:6
1,036 shares@ US$84.410.0012% mcap1.4% of flowCommon StockSEC:0001578852-26-000020:7
645 shares@ US$85.840.0007% mcap0.9% of flowCommon StockSEC:0001578852-26-000020:8
745 shares@ US$86.380.0009% mcap1.0% of flowCommon StockSEC:0001578852-26-000020:9
2,012 sharesCommon StockSEC:0001578852-26-000018:3
309 sharesCommon StockSEC:0001578852-26-000018:5
8,510 sharesCommon StockSEC:0001578852-26-000018:0
6,600 sharesCommon StockSEC:0001578852-26-000018:1
1,850 sharesCommon StockSEC:0001578852-26-000018:2
1,703 sharesCommon StockSEC:0001578852-26-000018:4
2,265 shares@ US$39.421.5% of flowCommon StockSEC:0001578852-26-000012:0
822 shares@ US$68.911.0% of flowCommon StockSEC:0001578852-26-000012:1
1,443 shares@ US$69.751.7% of flowCommon StockSEC:0001578852-26-000012:2
588 shares@ US$68.540.5% of flowCommon StockSEC:0001578852-26-000010:0
2,813 shares@ US$25.690.9% of flowCommon StockSEC:0001578852-26-000008:0
2,482 shares@ US$76.562.3% of flowCommon StockSEC:0001578852-26-000006:0
25 of 70 declarations
About Boulding Mark Elliott
Boulding Mark Elliott is Executive Vice President and Chief Legal Officer. He has 67 filings in total, all included in the recent sample, and the transactions recorded over the period from 2021-07-12 to 2026-07-08 show sell volume of EUR 2560556, with the dominant transaction nature stated as Disposition. The largest recent filings concern PTC Therapeutics, INC., including EUR 1380075.46731931 on 2025-03-12, EUR 609331.302997165 on 2025-10-07, and EUR 579158.4161537292 on 2025-09-15.
